WillItSurvive
Medical technology and health companies · United States

Definitive Healthcare

definitivehc.com ↗

Sells subscription access to healthcare provider and claims data for sales and market teams.

Little protection left
Assessed 22 July 2026 · Evidence as of 22 July 2026
Not much stands between this business and its pressures.
On the recordSince 22 July 2026 · Checkable from December 15, 2026 · Every call on the record Checkpoint: Nasdaq delisting deadline, stock must hold $1.00 for 10 straight business days before this date
The call

Revenue, customers, and headcount are all shrinking at the same time AI tools start doing parts of its job for free, with a delisting deadline in December 2026.

Definitive Healthcare sells information about doctors, hospitals, and health spending to insurance companies, drugmakers, and consultants. It is getting squeezed from two sides: big established players like IQVIA are taking market share, and new AI tools like Microsoft Copilot Health and ChatGPT Health can generate similar insights without buying expensive databases. The company's own customers are leaving (only 85% stay each year versus 109% at rivals), and its stock price is so low that it has until December 2026 to climb back above $0.70 or get kicked off the Nasdaq. The one thing that could save it is if management announces a buyer or a plan to go private before that deadline.

Why
01
AI pressure: Microsoft Copilot Health, OpenAI ChatGPT Health, Anthropic Claude for Healthcare. General AI health assistants could answer commercial intelligence questions directly, cutting demand for a paid data subscription. Could AI do the core job? Yes, likely.
02
Bigger players: IQVIA. IQVIA's bigger claims and provider datasets keep pulling large customers away, and Definitive's enterprise count keeps falling. Could a giant copy it? Yes, easily.
03
What protects it. Licensed claims data and existing integrations into customer sales workflows, though neither has stopped customers leaving.
What would change this call
Whether DH stock closes above $1.00 for 10 straight business days before December 15, 2026. Shows whether Definitive Healthcare avoids Nasdaq delisting.
NRR figure reported in Q2 2026 and Q3 2026 earnings. Shows whether customer retention is stabilizing or still eroding below 90%.
Any announcement of a take-private deal or acquisition by IQVIA, Clarivate, Veeva, or a PE firm. Shows whether a buyer sees enough value to rescue the company before delisting.
Key numbers
  • Net revenue retention 85% vs 109% peer median (2026-03-30)
  • Revenue guidance $220-226M, down 6-9% YoY (2026-05-07)
  • Headcount down 18.6% in 2025 to 659 employees (2026-06-29)
Named risks
  • Nasdaq delisting if share price stays below $1.00 through Dec 15, 2026. Severity: high
  • Continued revenue decline, guided at 6-9% YoY drop for FY2026. Severity: high
  • Net Revenue Retention stuck at 85%, well below peer median, signaling churn. Severity: high
  • Repeated goodwill impairments ($176.5M in Q1 2025, $197.2M in Q1 2026). Severity: medium
  • AI-native platform entrants (Copilot Health, ChatGPT Health, Claude for Healthcare) encroaching on adjacent territory. Severity: medium
Rivals, as read in July 2026
RivalDirectionEvidence
IQVIAlosing toDescribed as far larger-scale incumbent with bigger contracts as of 2026 comparisons
Microsoft Copilot Healthgaining onLaunched 2026-03-12 integrating 50+ wearables and EHR data from 50,000+ providers
Komodo HealthcontestingClaims mapping 330M patients across 65B+ encounters, per 2026-06-02 report
ZoomInfocontestingBroader contact database of 500M+ contacts encroaching on healthcare GTM use cases
Questions people ask
Is Definitive Healthcare profitable in 2026?
No. Definitive Healthcare posted a $199.3M net loss for FY2025 (10-K filed 2026-02-26) and a $192.4M net loss in Q1 2026, driven by a $197.2M goodwill impairment charge disclosed 2026-05-07.
Will Definitive Healthcare be delisted from Nasdaq?
It risks it. Nasdaq notified the company on 2026-06-18 that its stock fell below the $1.00 minimum bid price, starting a 180-day compliance window until 2026-12-15. Shares traded around $0.70-0.76 as of 2026-07-22.
Who is Definitive Healthcare's biggest competitor?
IQVIA is the dominant incumbent in healthcare commercial intelligence, described as far larger in scale and contract size than Definitive Healthcare. Definitive also faces claims-data rivals like Komodo Health and broader B2B data providers like ZoomInfo.
Could AI replace Definitive Healthcare?
Its list-building and search layer is exposed: Microsoft Copilot Health launched 2026-03-12 and OpenAI's ChatGPT Health and Anthropic's Claude for Healthcare launched January 2026, moving into adjacent healthcare-insight territory while Definitive's own Net Revenue Retention sits at 85% as of FY2024-Q4.
Who owns Definitive Healthcare?
Definitive Healthcare Corp. has traded publicly on Nasdaq as DH since its IPO on 2021-09-17, which raised roughly $420-453M at $27.00 per share. Advent International held a majority pre-IPO stake acquired in 2019 via AIDH TopCo, LLC.
Is Definitive Healthcare's revenue growing or shrinking?
Shrinking. Q1 2026 revenue was $55.9M, down 6% year over year, and FY2026 guidance calls for $220-226M in revenue, a 6-9% year-over-year decline, per company guidance issued 2026-05-07.
Timeline
  • 2026-07-18Wall Street Zen cuts Definitive Healthcare rating from Buy to Hold
  • 2026-06-29BofA Securities downgrades DH to Underperform, cuts target to $0.70 from $3.50
  • 2026-06-18Nasdaq notifies DH of 180-day compliance period for $1.00 minimum bid price rule
  • 2026-05-21DH announces expanded Atlas claims data, AI search, HubSpot and Salesforce integrations
  • 2026-05-07Q1 2026 results: revenue $55.9M (-6% YoY), net loss $192.4M on $197.2M goodwill impairment
  • 2026-03-12Microsoft publicly launches Copilot Health
  • 2026-02-2610-K filed reporting FY2025 net loss of $199.3M
  • 2026-01OpenAI ChatGPT Health and Anthropic Claude for Healthcare launch
  • 2023-01Definitive Healthcare discloses ~6% workforce reduction restructuring
  • 2021-09-17Definitive Healthcare IPOs on Nasdaq at $27.00 per share, raising ~$420-453M
Revision history
22 July 2026
First assessed. Little protection left. The text above is fixed as of this date and is not edited afterwards.
In the same band
Winning Health TechnologyCarbon Health111 Inc
More in Medical technology and health companies →
Sources